Emerging Trends in Cancer Research
- 1st Edition - May 6, 2026
- Latest edition
- Editors: Ranjita Shegokar, Yashwant Pathak
- Language: English
Emerging Trends in Cancer Research provides a comprehensive and up-to-date exploration of the latest advancements in cancer therapeutics, diagnostics, and intellectual proper… Read more
Readers will find coverage of clinical pipeline developments, intellectual property landscapes, and advancements in cancer therapeutics, diagnostics, and global drug delivery trends. This book is an invaluable resource for oncology, biomedical engineering, and pharmaceutical professionals, offering insights into the latest cancer research trends. It includes real-world case studies, practical applications, and discussions on regulatory and ethical considerations, making it essential for both seasoned researchers and graduate students.
- Provides comprehensive, up-to-date insights into the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes, covering a wide range of cancers (intestinal, cardiac, brain, and blood cancers)
- Delivers detailed analyses of drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments
- Includes real-world case studies and practical applications, along with discussions on regulatory and ethical considerations
2. Kidney-Urinary Bladder Cancer—Biomarkers Trends
3. Importance of Diagnostics in Cardiac Cancer
4. Brain Cancer—Preclinical Model Updates
5. What’s New in Liver Cancer Clinical Pipeline
6. Lung Cancer: IP Landscape
7. Colorectal Cancer Clinical Updates
8. Breast Cancer IP Landscape
9. Prostate Cancer Drugs in Clinical Trials
10. Global Trends and Intellectual Property Landscape Focusing on Drug Delivery for Oral Cancer Treatment
11. Sodium-Linolenic Channels in Cancer Diagnostics
12. Oral Cancer Therapeutics
13. Oral Cancer Microenvironments
14. mRNA Trends in Cancer Therapeutics
15. Blood Cancer Therapeutics
16. Colorectal Diagnostics
- Edition: 1
- Latest edition
- Published: May 6, 2026
- Language: English
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
YP
Yashwant Pathak
Yashwant Pathak, is Professor, Taneja College of Pharmacy, at the University of South Florida. Tampa, USA. His area of research is nanotechnology, drug delivery systems and nutraceuticals. He is also Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.